
Oct 5, 2024, 09:22
Doublet Immunotherapy Options for Unresectable Hepatocellular Carcinoma
The ASCO Post shared a post on X:
“Ghassan K. Abou-Alfa, MD, MBA, FASCO, and Lorenza Rimassa, MD, on Doublet Immunotherapy Options for Unresectable Hepatocellular Carcinoma.”
Source: The ASCO Post/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 26, 2025, 19:51
Mar 26, 2025, 18:12
Mar 26, 2025, 18:03